DSGN
#2489
Design Therapeutics, Inc. - Common Stock
15.1 1 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.92%
Monthly Change
+25.39%
6 month change
+44.46%
Year Change
+173.73%
Previous Close
15.2 5
Open
15.1 1
Low
15.1 1
High
15.1 1
Volume
72
Financials
- Market Capitalization 945.61 M
- Employee 55
- Founded 2017
- CEO N/A
- Website www.designtx.com
- Headquarter Delaware, United States
- FIGI BBG00SNC49V8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2469 |  GERN Geron Corporation - Common Stock | 1.51 USD | -1.31% | -1.31% | +6.34% | +7.86% | 970.13 M USD | ||
| 2485 |  ARDX Ardelyx, Inc. - Common Stock | 3.81 USD | -0.26% | -1.80% | -23.34% | -40.00% | 949.40 M USD | ||
| 2492 |  ANNX Annexon, Inc. - common stock | 4.97 USD | -5.33% | -1.58% | +1.84% | +141.26% | 942.21 M USD | ||
| 2505 |  IVA Inventiva S.A. - American Depository Shares | 4.71 USD | -3.88% | +2.39% | +4.43% | -14.21% | 910.15 M USD |
Frequently asked questions about Design Therapeutics, Inc. Common Stock
What is the Design Therapeutics, Inc. Common Stock stock price today?
The current price of Design Therapeutics, Inc. Common Stock (DSGN) is 15.11. Over the past 24 hours, the stock has changed by -0.92%. Follow the DSGN chart for real-time price dynamics.
What is the stock ticker of Design Therapeutics, Inc. Common Stock?
Design Therapeutics, Inc. Common Stock trades under the ticker DSGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Design Therapeutics, Inc. Common Stock stock going up?
DSGN has changed by +1.34% over the last week, +25.39% over the last month, and +173.73% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Design Therapeutics, Inc. Common Stock?
Design Therapeutics, Inc. Common Stock currently has a market capitalization of 945.61 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Design Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Design Therapeutics, Inc. Common Stock reported earnings of -0.32 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Design Therapeutics, Inc. Common Stock revenue for the last quarter?
Design Therapeutics, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Design Therapeutics, Inc. Common Stock net income for the last quarter?
Design Therapeutics, Inc. Common Stock reported net income of -20.16 M for the last quarter. The previous quarter showed -17.64 M, which means net income changed by -14.34%.
How many employees does Design Therapeutics, Inc. Common Stock have?
As of the latest available data, Design Therapeutics, Inc. Common Stock has 55 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Design Therapeutics, Inc. Common Stock stock?
You can buy Design Therapeutics, Inc. Common Stock (DSGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Design Therapeutics, Inc. Common Stock stock?
Investing in Design Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DSGN chart and related analysis on metatrader.com as part of your research.